Neurovascular Injury in Diabetic Retinopathy; Experimental Models, Pathophysiology and Potential new Therapeutic Targets
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: closed (25 March 2021) | Viewed by 10246
Special Issue Editor
Interests: vascular biology; angiogenesis; neurodegenertion; diabetes; Inflammation; Bioactive lipids; Bone morphogenetic protein; Oxidative stress; Diabetic retinopathy; age-related macular degeneration
Special Issue Information
Diabetic retinopathy (DR) is recognized to be a major neurovascular complication of diabetes mellitus and the leading cause of blindness among working adults worldwide that causes a significant socioeconomic burden. Despite advances in therapeutic interventions and our understanding of the underlying mechanisms of DR, there is still an urgent need to identify novel therapeutic targets that may overcome the limitations of current therapies. This Special Issue aims to highlight the experimental models that are used to investigate the neurovascular injury and characterize the crosstalk between retinal neuronal and vascular cells in diabetic retinopathy, the underlying molecular and cellular mechanisms, and to underscore potential new therapeutic targets. This Special Issue can include 1) in vitro and/or in vivo models of neuronal injury or endothelial cell dysfunction, 2) molecular and cellular mechanisms of neuronal or vascular dysfunction in DR, and 3) potential therapeutic interventions (pharmacological, molecular or cellular approaches) that target neuronal and vascular alterations in DR.
Prof. Mohamed Al-Shabrawey
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Diabetic Retinopathy
- Angiogenesis
- Macular edema
- Blood retinal barrier
- Neurodegeneration
- Inflammation
- Oxidative stress
- Glia cells
- Microglia